KROS logo

Keros Therapeutics (KROS) Enterprise Value

Enterprise Value

-$69.87 M
-$7.70 M-12.38%

1 min ago


Summary


Performance

KROS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherKROSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

KROS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-12.4%-1.7%-1.7%
1 m1 month-97.2%-7.2%-7.2%
3 m3 months-103.8%-81.0%-81.0%
6 m6 months-105.3%-74.1%-76.0%
ytdytd-153.8%-31.1%-31.1%
1 y1 year-103.4%-81.4%-83.5%
5 y5 years---

KROS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-138.0%-$100 M+30.0%
3 m3-month$2.27 B-103.1%-$100 M+30.0%
6 m6-month$2.27 B-103.1%-$100 M+30.0%
1 y1-year$2.27 B-103.1%-$100 M+30.0%
3 y3-year$2.27 B-103.1%-$100 M+30.0%
5 y5-year$2.27 B-103.1%-$100 M+30.0%
alltimeall time$2.27 B-103.1%-$100 M+30.0%

Keros Therapeutics Enterprise Value History

DateValue
2025
-$69.87 M(-153.8%)
2024
$129.83 M(-86.3%)
2023
$948.03 M(-10.3%)
DateValue
2022
$1.06 B(-10.0%)
2021
$1.17 B(-14.4%)
2020
$1.37 B

FAQ

  • What is Keros Therapeutics enterprise value?
  • What is the all time high enterprise value for Keros Therapeutics?
  • What is KROS enterprise value year-to-date change?
  • What is Keros Therapeutics enterprise value year-on-year change?

What is Keros Therapeutics enterprise value?

The current enterprise value of KROS is -$69.87 M

What is the all time high enterprise value for Keros Therapeutics?

Keros Therapeutics all-time high enterprise value is $2.27 B

What is KROS enterprise value year-to-date change?

Keros Therapeutics enterprise value has changed by -$199.70 M (-153.81%) since the beginning of the year

What is Keros Therapeutics enterprise value year-on-year change?

Over the past year, KROS enterprise value has changed by -$2.13 B (-103.39%)